0
Upcoming Allied Market Research
2023
Extremities Market

Extremities Market

by Product (Upper extremities, Lower extremities): Global Opportunity Analysis and Industry Forecast, 2023-2032

Report Code: A01217
Nov 2023 | Pages: NA
Tables: NA
Charts: NA
  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Extremities Market

Request Now !

Body extremities are extended organs mainly involved in locomotive functions. The human body has four extremities i.e. two upper limbs and two lower limbs. The extremities market is a small portion of the orthopedic industry. The joint reconstruction procedures involve modification of the body extremities. The human skeleton has more than 200 bones which are supported by tendons, ligaments and muscles. Hence, the prime focus of orthopedic industries was manufacture of devices and treatment procedures for joints, spine, knee and hip. But, now-a-days the focus of leading players on extremities market is increasing day by day as they offer better treatment options and provide growth opportunities to the key players.

The world extremities market is driven by the increase in the number of cases for orthopedic surgeons several factors such as increase in ageing population, awareness of the people for better treatment options and their expectations for a good quality of living. In addition, changes in the clinical practice patterns such as use of reversed shoulder instead of anatomic shoulder, use of arthroplasty procedure as an alternative to ankle fusion and increased use of implants in foot and ankle surgeries will also boost the market growth. Apart from this, development of new improved shoulders and ankles and need for less invasive devices will further propel the market growth. But the high unmet need for early diagnosis due to long waiting time in some countries is expected to hamper the market growth.

World extremities market is segmented on the basis of products and geography. Based on products, the market is segmented mainly into upper extremities and lower extremities. Upper extremities segment is further sub segmented into shoulder, elbow and hand & wrist. Lower extremities segment is further sub segmented into knee, hip and foot & ankle. The geographical classification includes North America, Europe, Asia-Pacific and LAMEA regions.

As the extremities market is in the expansion phase, mergers and acquisitions are frequent in this market. In October 2015 Wright Medical Group, Inc. and Tornier N.V merged together to form Wright Medical Group N.V. This has helped the company to establish themselves as the premier, high-growth extremities-biologics company and extend its leadership position and further accelerate its growth opportunities.
Key players in this market include DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Integra Lifesciences Holdings Corporation, Wright Medical Group N.V., Exactech, Inc., Arthrex, Inc., CONMED Corporation and Skeletal Dynamics LLC.

KEY MARKET BENEFITS:

  • The study provides an in-depth analysis of the world extremities market with current trends and future estimations to elucidate the imminent investment pockets.
  • The report provides a quantitative analysis which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis by product helps in understanding the various types of devices used.
  • Competitive intelligence highlights the business practices followed by leading players across various regions.
  • Comprehensive analysis of all geographic regions are provided that helps in determining the prevailing opportunities in these geographies
  • Key market players within the world extremities market are profiled in the report and their strategies are analysed thoroughly, which helps in understanding competitive outlook of the global market
  • Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework

Extremities Market Report Highlights

Aspects Details
By Product
  • Upper extremities
    • Shoulder
    • Elbow
    • Hand & wrist
  • Lower extremities
    • Hip
    • Knee
    • Foot & ankle
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Egypt, Rest of LAMEA)
Key Market Players Skeletal Dynamics LLC., Exactech, Inc., Arthrex, Inc., Zimmer Biomet Holdings, Inc., Wright Medical Group N.V., DePuy Synthes (a wholly owned subsidiary of Johnson & Johnson), Stryker Corporation, Smith & Nephew plc, CONMED Corporation, Integra Lifesciences Holdings Corporation
 
  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: EXTREMITIES MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Upper Extremities

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

      • 4.2.4. Shoulder

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Elbow

        • 4.2.4.1. Market Size and Forecast
      • 4.2.4. Hand wrist

        • 4.2.4.1. Market Size and Forecast
    • 4.3. Lower Extremities

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

      • 4.3.4. Hip

        • 4.3.4.1. Market Size and Forecast
      • 4.3.4. Knee

        • 4.3.4.1. Market Size and Forecast
      • 4.3.4. Foot ankle

        • 4.3.4.1. Market Size and Forecast
  • CHAPTER 5: EXTREMITIES MARKET, BY REGION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Region

    • 5.2. North America

      • 5.2.1. Key Market Trends and Opportunities

      • 5.2.2. Market Size and Forecast, By Product

      • 5.2.3. Market Size and Forecast, By Country

      • 5.2.4. U.S. Extremities Market

        • 5.2.4.1. Market Size and Forecast, By Product
      • 5.2.5. Canada Extremities Market

        • 5.2.5.1. Market Size and Forecast, By Product
      • 5.2.6. Mexico Extremities Market

        • 5.2.6.1. Market Size and Forecast, By Product
    • 5.3. Europe

      • 5.3.1. Key Market Trends and Opportunities

      • 5.3.2. Market Size and Forecast, By Product

      • 5.3.3. Market Size and Forecast, By Country

      • 5.3.4. France Extremities Market

        • 5.3.4.1. Market Size and Forecast, By Product
      • 5.3.5. Germany Extremities Market

        • 5.3.5.1. Market Size and Forecast, By Product
      • 5.3.6. Italy Extremities Market

        • 5.3.6.1. Market Size and Forecast, By Product
      • 5.3.7. Spain Extremities Market

        • 5.3.7.1. Market Size and Forecast, By Product
      • 5.3.8. UK Extremities Market

        • 5.3.8.1. Market Size and Forecast, By Product
      • 5.3.9. Russia Extremities Market

        • 5.3.9.1. Market Size and Forecast, By Product
      • 5.3.10. Rest Of Europe Extremities Market

        • 5.3.10.1. Market Size and Forecast, By Product
    • 5.4. Asia-Pacific

      • 5.4.1. Key Market Trends and Opportunities

      • 5.4.2. Market Size and Forecast, By Product

      • 5.4.3. Market Size and Forecast, By Country

      • 5.4.4. China Extremities Market

        • 5.4.4.1. Market Size and Forecast, By Product
      • 5.4.5. Japan Extremities Market

        • 5.4.5.1. Market Size and Forecast, By Product
      • 5.4.6. India Extremities Market

        • 5.4.6.1. Market Size and Forecast, By Product
      • 5.4.7. South Korea Extremities Market

        • 5.4.7.1. Market Size and Forecast, By Product
      • 5.4.8. Australia Extremities Market

        • 5.4.8.1. Market Size and Forecast, By Product
      • 5.4.9. Thailand Extremities Market

        • 5.4.9.1. Market Size and Forecast, By Product
      • 5.4.10. Malaysia Extremities Market

        • 5.4.10.1. Market Size and Forecast, By Product
      • 5.4.11. Indonesia Extremities Market

        • 5.4.11.1. Market Size and Forecast, By Product
      • 5.4.12. Rest of Asia Pacific Extremities Market

        • 5.4.12.1. Market Size and Forecast, By Product
    • 5.5. LAMEA

      • 5.5.1. Key Market Trends and Opportunities

      • 5.5.2. Market Size and Forecast, By Product

      • 5.5.3. Market Size and Forecast, By Country

      • 5.5.4. Brazil Extremities Market

        • 5.5.4.1. Market Size and Forecast, By Product
      • 5.5.5. South Africa Extremities Market

        • 5.5.5.1. Market Size and Forecast, By Product
      • 5.5.6. Saudi Arabia Extremities Market

        • 5.5.6.1. Market Size and Forecast, By Product
      • 5.5.7. UAE Extremities Market

        • 5.5.7.1. Market Size and Forecast, By Product
      • 5.5.8. Argentina Extremities Market

        • 5.5.8.1. Market Size and Forecast, By Product
      • 5.5.9. Rest of LAMEA Extremities Market

        • 5.5.9.1. Market Size and Forecast, By Product
  • CHAPTER 6: COMPETITIVE LANDSCAPE

    • 6.1. Introduction

    • 6.2. Top Winning Strategies

    • 6.3. Product Mapping Of Top 10 Player

    • 6.4. Competitive Dashboard

    • 6.5. Competitive Heatmap

    • 6.6. Top Player Positioning,2022

  • CHAPTER 7: COMPANY PROFILES

    • 7.1. DePuy Synthes (a Wholly Owned Subsidiary Of Johnson And Johnson)

      • 7.1.1. Company Overview

      • 7.1.2. Key Executives

      • 7.1.3. Company Snapshot

      • 7.1.4. Operating Business Segments

      • 7.1.5. Product Portfolio

      • 7.1.6. Business Performance

      • 7.1.7. Key Strategic Moves and Developments

    • 7.2. Stryker Corporation

      • 7.2.1. Company Overview

      • 7.2.2. Key Executives

      • 7.2.3. Company Snapshot

      • 7.2.4. Operating Business Segments

      • 7.2.5. Product Portfolio

      • 7.2.6. Business Performance

      • 7.2.7. Key Strategic Moves and Developments

    • 7.3. Zimmer Biomet Holdings, Inc.

      • 7.3.1. Company Overview

      • 7.3.2. Key Executives

      • 7.3.3. Company Snapshot

      • 7.3.4. Operating Business Segments

      • 7.3.5. Product Portfolio

      • 7.3.6. Business Performance

      • 7.3.7. Key Strategic Moves and Developments

    • 7.4. Smith And Nephew Plc

      • 7.4.1. Company Overview

      • 7.4.2. Key Executives

      • 7.4.3. Company Snapshot

      • 7.4.4. Operating Business Segments

      • 7.4.5. Product Portfolio

      • 7.4.6. Business Performance

      • 7.4.7. Key Strategic Moves and Developments

    • 7.5. Integra Lifesciences Holdings Corporation

      • 7.5.1. Company Overview

      • 7.5.2. Key Executives

      • 7.5.3. Company Snapshot

      • 7.5.4. Operating Business Segments

      • 7.5.5. Product Portfolio

      • 7.5.6. Business Performance

      • 7.5.7. Key Strategic Moves and Developments

    • 7.6. Wright Medical Group N.V.

      • 7.6.1. Company Overview

      • 7.6.2. Key Executives

      • 7.6.3. Company Snapshot

      • 7.6.4. Operating Business Segments

      • 7.6.5. Product Portfolio

      • 7.6.6. Business Performance

      • 7.6.7. Key Strategic Moves and Developments

    • 7.7. Exactech, Inc.

      • 7.7.1. Company Overview

      • 7.7.2. Key Executives

      • 7.7.3. Company Snapshot

      • 7.7.4. Operating Business Segments

      • 7.7.5. Product Portfolio

      • 7.7.6. Business Performance

      • 7.7.7. Key Strategic Moves and Developments

    • 7.8. Arthrex, Inc.

      • 7.8.1. Company Overview

      • 7.8.2. Key Executives

      • 7.8.3. Company Snapshot

      • 7.8.4. Operating Business Segments

      • 7.8.5. Product Portfolio

      • 7.8.6. Business Performance

      • 7.8.7. Key Strategic Moves and Developments

    • 7.9. CONMED Corporation

      • 7.9.1. Company Overview

      • 7.9.2. Key Executives

      • 7.9.3. Company Snapshot

      • 7.9.4. Operating Business Segments

      • 7.9.5. Product Portfolio

      • 7.9.6. Business Performance

      • 7.9.7. Key Strategic Moves and Developments

    • 7.10. Skeletal Dynamics LLC.

      • 7.10.1. Company Overview

      • 7.10.2. Key Executives

      • 7.10.3. Company Snapshot

      • 7.10.4. Operating Business Segments

      • 7.10.5. Product Portfolio

      • 7.10.6. Business Performance

      • 7.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL EXTREMITIES MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL EXTREMITIES MARKET FOR UPPER EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL EXTREMITIES MARKET FOR LOWER EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL EXTREMITIES MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. NORTH AMERICA EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. NORTH AMERICA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 7. U.S. EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 8. CANADA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 9. MEXICO EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 10. EUROPE EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. EUROPE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 12. FRANCE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 13. GERMANY EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 14. ITALY EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 15. SPAIN EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 16. UK EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 17. RUSSIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. REST OF EUROPE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 19. ASIA-PACIFIC EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. ASIA-PACIFIC EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. CHINA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 22. JAPAN EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. INDIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. SOUTH KOREA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 25. AUSTRALIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 26. THAILAND EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. MALAYSIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 28. INDONESIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 29. REST OF ASIA PACIFIC EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 30. LAMEA EXTREMITIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 31. LAMEA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 32. BRAZIL EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 33. SOUTH AFRICA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. SAUDI ARABIA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. UAE EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 36. ARGENTINA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. REST OF LAMEA EXTREMITIES, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 38. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): KEY EXECUTIVES
  • TABLE 39. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): COMPANY SNAPSHOT
  • TABLE 40. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): OPERATING SEGMENTS
  • TABLE 41. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): PRODUCT PORTFOLIO
  • TABLE 42. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 43. STRYKER CORPORATION: KEY EXECUTIVES
  • TABLE 44. STRYKER CORPORATION: COMPANY SNAPSHOT
  • TABLE 45. STRYKER CORPORATION: OPERATING SEGMENTS
  • TABLE 46. STRYKER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 47. STRYKER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 48. ZIMMER BIOMET HOLDINGS, INC.: KEY EXECUTIVES
  • TABLE 49. ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT
  • TABLE 50. ZIMMER BIOMET HOLDINGS, INC.: OPERATING SEGMENTS
  • TABLE 51. ZIMMER BIOMET HOLDINGS, INC.: PRODUCT PORTFOLIO
  • TABLE 52. ZIMMER BIOMET HOLDINGS, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 53. SMITH AND NEPHEW PLC: KEY EXECUTIVES
  • TABLE 54. SMITH AND NEPHEW PLC: COMPANY SNAPSHOT
  • TABLE 55. SMITH AND NEPHEW PLC: OPERATING SEGMENTS
  • TABLE 56. SMITH AND NEPHEW PLC: PRODUCT PORTFOLIO
  • TABLE 57. SMITH AND NEPHEW PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 58. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 59. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 60. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
  • TABLE 61. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 62. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 63. WRIGHT MEDICAL GROUP N.V.: KEY EXECUTIVES
  • TABLE 64. WRIGHT MEDICAL GROUP N.V.: COMPANY SNAPSHOT
  • TABLE 65. WRIGHT MEDICAL GROUP N.V.: OPERATING SEGMENTS
  • TABLE 66. WRIGHT MEDICAL GROUP N.V.: PRODUCT PORTFOLIO
  • TABLE 67. WRIGHT MEDICAL GROUP N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 68. EXACTECH, INC.: KEY EXECUTIVES
  • TABLE 69. EXACTECH, INC.: COMPANY SNAPSHOT
  • TABLE 70. EXACTECH, INC.: OPERATING SEGMENTS
  • TABLE 71. EXACTECH, INC.: PRODUCT PORTFOLIO
  • TABLE 72. EXACTECH, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 73. ARTHREX, INC.: KEY EXECUTIVES
  • TABLE 74. ARTHREX, INC.: COMPANY SNAPSHOT
  • TABLE 75. ARTHREX, INC.: OPERATING SEGMENTS
  • TABLE 76. ARTHREX, INC.: PRODUCT PORTFOLIO
  • TABLE 77. ARTHREX, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 78. CONMED CORPORATION: KEY EXECUTIVES
  • TABLE 79. CONMED CORPORATION: COMPANY SNAPSHOT
  • TABLE 80. CONMED CORPORATION: OPERATING SEGMENTS
  • TABLE 81. CONMED CORPORATION: PRODUCT PORTFOLIO
  • TABLE 82. CONMED CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 83. SKELETAL DYNAMICS LLC.: KEY EXECUTIVES
  • TABLE 84. SKELETAL DYNAMICS LLC.: COMPANY SNAPSHOT
  • TABLE 85. SKELETAL DYNAMICS LLC.: OPERATING SEGMENTS
  • TABLE 86. SKELETAL DYNAMICS LLC.: PRODUCT PORTFOLIO
  • TABLE 87. SKELETAL DYNAMICS LLC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • LIST OF FIGURES

  • FIGURE 1. GLOBAL EXTREMITIES MARKET SEGMENTATION
  • FIGURE 2. GLOBAL EXTREMITIES MARKET
  • FIGURE 3. SEGMENTATION EXTREMITIES MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN EXTREMITIES MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALEXTREMITIES MARKET
  • FIGURE 11. EXTREMITIES MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. EXTREMITIES MARKET FOR UPPER EXTREMITIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. EXTREMITIES MARKET FOR LOWER EXTREMITIES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 15. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 16. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 17. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 18. COMPETITIVE DASHBOARD
  • FIGURE 19. COMPETITIVE HEATMAP: EXTREMITIES MARKET
  • FIGURE 20. Top player positioning, 2022
  • FIGURE 21. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): NET SALES, 2020-2022 ($MILLION)
  • FIGURE 22. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 23. DEPUY SYNTHES (A WHOLLY OWNED SUBSIDIARY OF JOHNSON AND JOHNSON): REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 24. STRYKER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 25. STRYKER CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 26. STRYKER CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 27. ZIMMER BIOMET HOLDINGS, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 28. ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 29. ZIMMER BIOMET HOLDINGS, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 30. SMITH AND NEPHEW PLC: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 31. SMITH AND NEPHEW PLC: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 32. SMITH AND NEPHEW PLC: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 33. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 34. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 35. INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 36. WRIGHT MEDICAL GROUP N.V.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 37. WRIGHT MEDICAL GROUP N.V.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 38. WRIGHT MEDICAL GROUP N.V.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 39. EXACTECH, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 40. EXACTECH, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 41. EXACTECH, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 42. ARTHREX, INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 43. ARTHREX, INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 44. ARTHREX, INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 45. CONMED CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 46. CONMED CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 47. CONMED CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 48. SKELETAL DYNAMICS LLC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 49. SKELETAL DYNAMICS LLC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 50. SKELETAL DYNAMICS LLC.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Extremities Market

Start reading.
This Report and over 68,245+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers